Author

Xindi Wang

University of TorontoPrimary ORCID profile (0000-0001-7249-3375 · 9 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Xindi WangiD9 papers · Montreal Neurological Institute and Hospital

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Greg L. BeilhartziD· 1 shared Huazhu LiangiD· 1 shared Kangni Zou· 1 shared Roman A. MelnykiD· 1 shared Shi Bo CaoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Greg L. BeilhartzORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Balancing receptor engagement and payload catalytic activity broadens the therapeutic window of immunotoxins

Huazhu Liang, Greg L. Beilhartz, Xindi Wang, Kangni Zou, Shi Bo Cao, Roman A. Melnyk

This study shows that reducing the catalytic activity of immunotoxins while balancing receptor engagement improves their selectivity and therapeutic window.

bioRxiv · Oct 2, 2026 · PreprintPharmacology & Toxicology